figshare
Browse
pone.0271707.g003.tif (497.78 kB)

Survivability is decreased in zebrafish embryos following exogenous treatment with an amino-terminal fragment of nApoE41-151.

Download (497.78 kB)
figure
posted on 2022-12-15, 18:55 authored by Madyson M. McCarthy, Makenna J. Hardy, Saylor E. Leising, Alex M. LaFollette, Erica S. Stewart, Amelia S. Cogan, Tanya Sanghal, Katie Matteo, Jonathon C. Reeck, Julia T. Oxford, Troy T. Rohn

A. Embryos at 24 hpf (prim-9 stage) were segregated into three groups: controls (untreated), 25 μg/ml or 50 μg/ml nApoE31-151, and 25 μg/ml or 50 μg/ml nApoE41-151. Embryos that lacked a heartbeat for 10 seconds were stimulated to induce movement. If no movement or heartbeat was detected, embryos were considered to be non-viable. Significant mortality was observed at both concentrations of nApoE41-151 by 48 hpf (orange and green dotted lines) compared to non-treated controls (orange dotted line) or nApoE31-151 (blue dashed line and black dotted lines). N = 3 independent trials, N = 5 fish/treatment. B. The Mosaic Plot depicts mortality based on a lack of heartbeat and response to physical stimuli following exogenous treatment of 48 hpf zebrafish embryos with either 25 μg/ml nApoE31-151 or nApoE41-151 for 24 hours. The blue filled region of the bar graph designates 25 μg/ml treatment of nApoE41-151 which led to a significant portion of the embryos being designated as dead. The red dotted portion of the bar graphs indicates less than expected were alive (p = 1.17e-13). All blank cells indicate the sample group followed the estimated trend. Data indicated significant morality for only the nApoE41-151 group. N = 3 independent experiments, 15 embryos/treatment.

History